Results of using the neuroprotective drug Cellex in non-traumatic intracranial hemorrhage
Introduction. In the Russian Federation, neuroprotective agents are widely used in the treatment of patients with ischemic stroke. There are accumulated data on the efficacy and safety of the neuroprotective agent Cellex® in ischemic stroke. The use of this drug in hemorrhagic stroke has been studie...
المؤلفون الرئيسيون: | Kh. D. Mongush, A. V. Kyrgys, A. A. Sedip, A. E. Shyyrap, A. B. Ondar, M. G. Zhestikova |
---|---|
التنسيق: | مقال |
اللغة: | Russian |
منشور في: |
Remedium Group LLC
2022-03-01
|
سلاسل: | Медицинский совет |
الموضوعات: | |
الوصول للمادة أونلاين: | https://www.med-sovet.pro/jour/article/view/6755 |
مواد مشابهة
-
Efficacy of Cellex in patients with mild cognitive impairment
حسب: B. A. Abusueva, وآخرون
منشور في: (2019-04-01) -
NEUROPROTECTION INFLUENCE ON COURSE OF CEREBRAL STROKE
حسب: G. N. BELSKAYA, وآخرون
منشور في: (2016-12-01) -
Neuroprotection by Ozanimod Following Intracerebral Hemorrhage in Mice
حسب: Fei Wang, وآخرون
منشور في: (2022-06-01) -
Drug-induced non-traumatic intracranial hemorrhage associated with the use of anticoagulants and antiplatelet agents
حسب: O. D. Ostroumova, وآخرون
منشور في: (2022-12-01) -
Acute albumin administration as therapy for intracerebral hemorrhage: A literature review
حسب: Yirong Cao, وآخرون
منشور في: (2024-01-01)